Cervical cancer screening for older women
Reducing the Burden of Cervical Cancer Among Older Women by Expanding the Screening Age and Offering HPV Self-sampling
This study tests if using HPV self-sampling for cervical cancer screening is effective for women aged 65 to 69 who haven't been screened in the last five years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 65 Years to 69 Years |
| Sex | Female |
| Sponsor | University of Aarhus Academic / other |
| Locations | 1 site (Randers, Randers NØ) |
| Trial ID | NCT04114968 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility and effectiveness of including women aged 65 to 69 in the Danish cervical cancer screening program. It focuses on the use of HPV self-sampling as a screening method for this age group. The study is a nationwide population-based cohort study that compares an intervention group receiving HPV-based screening to a control group receiving standard care. Eligible participants are women who have not had a cervical cytology sample or screening invitation in the last five years.
Who should consider this trial
Good fit: Ideal candidates for this study are Danish women aged 65 to 69 who have not been screened for cervical cancer in the past five years.
Not a fit: Patients who have had a hysterectomy or those who are not residents of Denmark may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve early detection of cervical cancer in older women, potentially leading to better health outcomes.
How similar studies have performed: Other studies have shown success with HPV self-sampling in cervical cancer screening, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 65 to 69 years; * Resident in Denmark * No record of a cervical cytology or screening invitation in the past 5 years * Not registered as ineligible for screening Exclusion Criteria: * Death * Migration to or from Denmark * Moving to or from the CDR * Residing in the CDR, but having GP in another region * A record of hysterectomy
Where this trial is running
Randers, Randers NØ
- Mette Tranberg Nielsen — Randers, Randers NØ, Denmark (Recruiting)
Study contacts
- Principal investigator: Mette T Tranberg, post doc phd — Randers Regional Hospital, Central Denmark Region
- Study coordinator: Mette Tranberg, Post doc PhD
- Email: mettrani@rm.dk
- Phone: +45 784 20264
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.